Skip to main content
ERAS
NASDAQ Life Sciences

Erasca Posts $51.3M Q3 Loss as $947.8M Cash Pile Funds RAS Pipeline

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$15.78
Mkt Cap
$5.519B
52W Low
$2.34
52W High
$24.28
52W Position info
574% above low
Off High info
35% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ERAS has more than doubled off its 52-week low of $2.34.

Summary

Erasca's Q3 net loss widened to $51.3M, or $0.15 per share, from $30.6M, or $0.11 per share, a year earlier, as spending on the RAS pipeline ramps up. The balance sheet is the story: cash, equivalents and marketable securities stood at $947.8M on September 30, up from $341.8M at December 31, 2025, which the company says covers its near-term milestones. That cushion is large relative to the company's size, so dilution risk near term is limited. Pipeline timing is the swing factor — preliminary ERAS-4001 data are expected in H2 2026, with ERAS-0015 data in H1 2027. The filing also discloses a new Revolution Medicines patent matter, a legal overhang worth tracking alongside the clinical readouts.

At the time of this announcement, ERAS was trading at $15.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $2.34 to $24.28. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ERAS - Latest Insights

ERAS
Nov 12, 2026, 4:03 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $15.78
Real-time Price: $15.10 info
Change: -$0.680 (-4%) info
Market Cap: $5.477B info
ERAS
Aug 24, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.11
Real-time Price: $15.10 info
Change: -$3.01 (-17%) info
Market Cap: $5.477B info
ERAS
Aug 24, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.11
Real-time Price: $15.10 info
Change: -$3.01 (-17%) info
Market Cap: $5.477B info
ERAS
Aug 11, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $18.31
Real-time Price: $15.10 info
Change: -$3.21 (-18%) info
Market Cap: $5.477B info
ERAS
Aug 11, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.31
Real-time Price: $15.10 info
Change: -$3.21 (-18%) info
Market Cap: $5.477B info